<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article article-type="case-report" dtd-version="1.1" specific-use="sps-1.9" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
	<front>
		<journal-meta>
			<journal-id journal-id-type="publisher-id">rfmun</journal-id>
			<journal-title-group>
				<journal-title>Revista de la Facultad de Medicina</journal-title>
				<abbrev-journal-title abbrev-type="publisher">rev.fac.med.</abbrev-journal-title>
			</journal-title-group>
			<issn pub-type="ppub">0120-0011</issn>
			<publisher>
				<publisher-name>Universidad Nacional de Colombia</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="doi">10.15446/revfacmed.v71n3.102546</article-id>
                        <article-id pub-id-type="other">11</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Reporte de casos</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Emphysematous pyelonephritis as a complication of staghorn calculi: A case report</article-title>
				<trans-title-group xml:lang="es">
					<trans-title>Pielonefritis enfisematosa como complicación de litiasis coraliforme: Reporte de un caso</trans-title>
				</trans-title-group>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0003-3385-1891</contrib-id>
					<name>
						<surname>Azañero-Haro</surname>
						<given-names>Johan</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
					<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
					<xref ref-type="corresp" rid="c1"><sup>*</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0003-2875-6777</contrib-id>
					<name>
						<surname>Segura-Gago</surname>
						<given-names>Gino</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
					<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0001-5891-281X</contrib-id>
					<name>
						<surname>Benavides-Samame</surname>
						<given-names>Alejandro</given-names>
					</name>
					<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0002-1536-7257 </contrib-id>
					<name>
						<surname>Chirinos-Molina</surname>
						<given-names>Tatiana</given-names>
					</name>
					<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0001-8648-8032</contrib-id>
					<name>
						<surname>Soto</surname>
						<given-names>Alonso</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
					<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
				</contrib>
			</contrib-group>
			<aff id="aff1">
				<label>1</label>
				<institution content-type="original"> Hospital Nacional Hipólito Unánue - Department of Internal Medicine - Lima - Peru.</institution>
				<institution content-type="orgname">Hospital Nacional Hipólito Unánue</institution>
				<institution content-type="orgdiv1">Department of Internal Medicine</institution>
				<addr-line>
					<city>Lima</city>
				</addr-line>
				<country country="PE">Peru</country>
			</aff>
			<aff id="aff2">
				<label>2</label>
				<institution content-type="original"> Universidad Científica del Sur - Graduate School - Lima - Peru.</institution>
				<institution content-type="normalized">Universidad Científica del Sur</institution>
				<institution content-type="orgname">Universidad Científica del Sur</institution>
				<addr-line>
					<city>Lima</city>
				</addr-line>
				<country country="PE">Peru</country>
			</aff>
			<aff id="aff3">
				<label>3</label>
				<institution content-type="original"> Universidad Nacional Mayor de San Marcos - Sociedad Científica de San Fernando - Lima - Peru.</institution>
				<institution content-type="normalized">Universidad Nacional Mayor de San Marcos</institution>
				<institution content-type="orgname">Universidad Nacional Mayor de San Marcos</institution>
				<addr-line>
					<city>Lima</city>
				</addr-line>
				<country country="PE">Peru</country>
			</aff>
			<aff id="aff4">
				<label>4</label>
				<institution content-type="original"> Hospital Nacional Hipólito Unánue - Department of Clinical Pathology and Anatomic Pathology - Lima - Peru.</institution>
				<institution content-type="orgname">Hospital Nacional Hipólito Unánue</institution>
				<institution content-type="orgdiv1">Department of Clinical Pathology and Anatomic Pathology</institution>
				<addr-line>
					<city>Lima</city>
				</addr-line>
				<country country="PE">Peru</country>
			</aff>
			<aff id="aff5">
				<label>5</label>
				<institution content-type="original"> Universidad Ricardo Palma - Faculty of Human Medicine - Instituto de Investigación en Ciencias Biomédicas - Lima - Peru.</institution>
				<institution content-type="normalized">Universidad Ricardo Palma</institution>
				<institution content-type="orgname">Universidad Ricardo Palma</institution>
				<institution content-type="orgdiv1">Faculty of Human Medicine</institution>
				<addr-line>
					<city>Lima</city>
				</addr-line>
				<country country="PE">Peru</country>
			</aff>
			<author-notes>
				<corresp id="c1">
					<label>*</label><bold>Corresponding author:</bold> Johan Azañero-Haro. Departamento de Medicina Interna, Hospital Nacional Hipólito Unánue. Lima. Peru. Email: <email>johan1675@gmail.com</email>.</corresp>
				<fn fn-type="conflict" id="fn4">
					<label>Conflicts of interest</label>
					<p> None stated by the authors. </p>
				</fn>
			</author-notes>
			<pub-date date-type="pub" publication-format="electronic">
				<day>15</day>
				<month>07</month>
				<year>2024</year>
			</pub-date>
			<pub-date date-type="collection" publication-format="electronic">
				<season>Jul-Sep</season>
				<year>2023</year>
			</pub-date>
			<volume>71</volume>
			<issue>3</issue>
			<elocation-id>e11</elocation-id>
			<history>
				<date date-type="received">
					<day>08</day>
					<month>05</month>
					<year>2022</year>
				</date>
				<date date-type="accepted">
					<day>25</day>
					<month>12</month>
					<year>2022</year>
				</date>
			</history>
			<permissions>
				<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xml:lang="en">
					<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License</license-p>
				</license>
			</permissions>
			<abstract>
				<title><italic>Abstract</italic></title>
				<sec>
					<title>Introduction: </title>
					<p>Emphysematous pyelonephritis is an infection with a high mortality rate, so having a high index of clinical suspicion is important to achieve a timely diagnosis and treatment. </p>
				</sec>
				<sec>
					<title>Case presentation: </title>
					<p>This is the case of a 47-year-old woman with diabetes mellitus, high blood pressure, chronic kidney disease, hypothyroidism and a history of recurrent acute pyelonephritis who was referred to a tertiary care hospital in Lima, Peru, due to colicky abdominal pain, tachycardia, fever, and chills. Leukocytosis, moderate anemia, leukocyturia and hyperlactacidemia were evidenced in the admission laboratory tests. In addition, a renal ultrasound showed staghorn calculi in the right kidney, while visualization of the left kidney was not possible, so she was hospitalized and antibiotic therapy with ceftriaxone was started. However, four days later, and despite the antibiotic therapy, the patient presented low blood pressure, leading to discontinuation of ceftriaxone, initiation of antibiotic therapy with meropenem-vancomycin and vasopressor therapy, and transfer to the critical care unit. The next day, due to the presence of intermittent fever, hypoactive delirium, persistent hypoglycemia and oligoanuria with purulent urine, a computerized tomography urogram was performed, which revealed bilateral staghorn calculi with presence of gas and air-fluid levels in the left kidney. Considering these findings, as well as her poor clinical condition, left nephrectomy was performed, achieving favorable clinical progress. The patient was discharged 7 days after the procedure.</p>
				</sec>
				<sec>
					<title>Conclusion: </title>
					<p>Emphysematous pyelonephritis should always be suspected in women with diabetes mellitus (and irregular adherence to treatment), poor response to antibiotic therapy, and staghorn calculi. Computed axial tomography allows reaching the diagnosis and determining prognosis, therefore, an appropriate treatment can be established.</p>
				</sec>
			</abstract>
			<trans-abstract xml:lang="es">
				<title><italic>Resumen</italic></title>
				<sec>
					<title>Introducción. </title>
					<p>La pielonefritis enfisematosa es una infección con una elevada tasa de mortalidad, por lo que es importante tener un alto índice de sospecha clínica para lograr un diagnóstico y tratamiento oportunos. </p>
				</sec>
				<sec>
					<title>Presentación del caso. </title>
					<p>Mujer de 47 años con diabetes <italic>mellitus,</italic> hipertensión arterial, enfermedad renal crónica, hipotiroidismo y antecedente de pielonefritis aguda recurrente, quien fue remitida a un hospital de tercer nivel de Lima, Perú, por dolor abdominal tipo cólico, taquicardia, fiebre y escalofríos. En las pruebas de laboratorio de ingreso se evidenció leucocitosis, anemia moderada, leucocituria e hiperlactacidemia; además, en la ecografía renal se observó litiasis coraliforme en el riñón derecho, mientras que no fue posible visualizar el riñón izquierdo, por lo que fue hospitalizada y se inició terapia antibiótica con ceftriaxona. Sin embargo, 4 días después, la paciente presentó hipotensión arterial a pesar de la antibioticoterapia, por lo cual se suspendió la ceftriaxona, se inició antibioticoterapia con meropenem-vancomicina y terapia de vasopresores y se trasladó a la unidad de cuidados críticos. Un día después, ante la presencia de fiebre intermitente, delirium hipoactivo, hipoglucemia persistente y oligoanuria con orina de aspecto purulento, se realizó una urografía por tomografía computarizada en la que se identificó litiasis coraliformes bilateral con presencia de gas y niveles hidroaéreos en el riñón izquierdo. Teniendo en cuenta estos hallazgos y la pobre evolución clínica, se realizó nefrectomía izquierda, con lo que se logró una favorable evolución clínica, siendo dada de alta a los 7 días luego de este procedimiento.</p>
				</sec>
				<sec>
					<title>Conclusión. </title>
					<p>La pielonefritis enfisematosa siempre debe sospecharse en mujeres con diabetes <italic>mellitus</italic> con tratamiento irregular, pobre respuesta a la terapia antibiótica y litiasis coraliforme. La tomografía axial computarizada no solo permite realizar su diagnóstico, sino también establecer su pronóstico y, por tanto, el tratamiento apropiado.</p>
				</sec>
			</trans-abstract>
			<kwd-group xml:lang="en">
				<title>Keywords:</title>
				<kwd>Pyelonephritis</kwd>
				<kwd>Staghorn Calculi</kwd>
				<kwd>Diabetes Mellitus</kwd>
				<kwd>Sepsis</kwd>
				<kwd>Chronic Kidney Disease</kwd>
				<kwd>Case Reports (MeSH)</kwd>
			</kwd-group>
			<kwd-group xml:lang="es">
				<title>Palabras clave:</title>
				<kwd>Pielonefritis</kwd>
				<kwd>Litiasis coraliformes</kwd>
				<kwd>Diabetes <italic>mellitus</italic></kwd>
				<kwd>Sepsis</kwd>
				<kwd>Enfermedad renal crónica</kwd>
				<kwd>Estudio de caso (DeCS)</kwd>
			</kwd-group>
			<counts>
				<fig-count count="4"/>
				<table-count count="1"/>
				<equation-count count="0"/>
				<ref-count count="19"/>
				<page-count count="0"/>
			</counts>
		</article-meta>
	</front>
	<body>
		<sec sec-type="intro">
			<title>Introduction</title>
			<p>Emphysematous pyelonephritis is a rare, acute, severe renal infection characterized by necrosis, abscesses and gas, which may involve both the renal parenchyma and perirenal tissues.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B2"><sup>2</sup></xref>This condition is more frequent in women (female-to-male ratio of 4:1)<xref ref-type="bibr" rid="B2"><sup>2</sup></xref> and may be the result of bacterial activity generated by diabetes mellitus (DM)<xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B4"><sup>4</sup></xref> and urinary obstruction caused by renal lithiasis.<xref ref-type="bibr" rid="B4"><sup>4</sup></xref> Emphysematous pyelonephritis leads to production of gas via the fermentation of glucose.<xref ref-type="bibr" rid="B5"><sup>5</sup></xref>
			</p>
			<p>The clinical course of patients with emphysematous pyelonephritis is variable and depends on early diagnosis and multidisciplinary treatment. In the 1970s and 1980s, the overall mortality rate for this condition was up to 78% in cases that did not receive timely care, with emergency nephrectomy being the only suitable treatment.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref> However, this rate has substantially decreased in recent decades with the early introduction of appropriate antibiotic therapy and multidisciplinary management.<xref ref-type="bibr" rid="B7"><sup>7</sup></xref>
			</p>
			<p>The following is the case of a patient with DM, high blood pressure, chronic kidney disease (CKD) on hemodialysis, bilateral staghorn calculi and recurrent urinary tract infections, who was diagnosed with emphysematous pyelonephritis.</p>
		</sec>
		<sec sec-type="cases">
			<title>Case presentation</title>
			<p>47-year-old woman with a history of high blood pressure (under treatment with losartan 100mg every 24 hours), DM (with poor adherence to therapy), CKD (being treated with hemodialysis 3 times a week in the last 2 years and with an approximate diuresis of 1 500 mL/24 hours) and hypothyroidism (under treatment with levothyroxine 50pg every 24 hours). In the last year, the patient had had two episodes of acute pyelonephritis that required hospitalization, and since she was diagnosed with stage 3 and 4 CKD (3 years earlier) she discontinued the use of hypoglycemic drugs. Due to CKD, the patient had moderate anemia and was being treated with parenteral iron and erythropoietin at each hemodialysis session because she presented a dramatic drop in hemoglobin levels after these interventions.</p>
			<p>During a regular hemodialysis session, the patient developed tachycardia, fever and chills, so she was referred to the emergency department of a tertiary care center in Lima, Peru. It should be noted that two days before admission she presented with colicky abdominal pain in the left flank that subsided with analgesics. On admission to the emergency department, the patient was conscious, hemodynamically stable and with the following vital signs: blood pressure: 120/78 mmHg, heart rate: 118 bpm, respiratory rate: 20 rpm, and temperature: 37.0°C. The physical examination also revealed pain on palpation in the left flank and positive bilateral kidney percussion.</p>
			<p>Laboratory tests on admission showed leukocytosis, moderate anemia, leukocyturia and high lactic acidosis (<xref ref-type="table" rid="t1">Table 1</xref>), so empirical antibiotic therapy was started with ceftriaxone 2g intravenous every 24 hours for 4 days. Given the unavailability of beds, the patient remained in the emergency room for 4 days before being admitted to the general inpatient ward.</p>
			<p>
				<table-wrap id="t1">
					<label>Table 1</label>
					<caption>
						<title>Laboratory tests.</title>
					</caption>
					<graphic xlink:href="0120-0011-rfmun-71-03-e11-gt1.png"/>
					<table-wrap-foot>
						<fn id="TFN1">
							<p>Source: Own elaboration.</p>
						</fn>
					</table-wrap-foot>
				</table-wrap>
			</p>
			<p>Renal ultrasound, performed 48 hours after admission, showed a 104x53mm right kidney with irregular borders, heterogeneous echotexture, poor corticomedullary differentiation, 4mm parenchyma, and lithiasis inside, but without signs of hydronephrosis. It was not possible to see the left kidney during this procedure, so a contrasted CT scan was requested, which, due to hospital availability limitations, could not be performed until the fifth day of hospitalization.</p>
			<p>After 96 hours of admission, the patient presented hypoactivity and high blood pressure with no response to hydration. Considering the suspicion of infection by resistant bacteria, it was decided to suspend ceftriaxone and initiate meropenem 500mg every 24 hours and vancomycin 500mg every 48 hours (dose adjusted according to the patient's renal function). Also, due to septic shock, norepinephrine was started at 1 pg/hour/min and transfer to the critical care unit was indicated.</p>
			<p>On the fifth day of admission, due to the persistence of intermittent fever (<xref ref-type="fig" rid="f1">Figure 1</xref>), hypoactive delirium and hypoglycemia, as well as the presence of oliguria with purulent urine and the need for vasopressors, a contrast computed tomography urogram was performed (<xref ref-type="fig" rid="f2">Figure 2</xref>), which showed the following: 1) right kidney of 108x54x43mm with staghorn calculi of 46x41x16mm inside and dilatation of the pyelocaliceal system of up to 23mm.; 2) left renal fossa of 236x87x88mm with loss of renal morphology due to the presence of gas and air-fluid levels (destruction of the renal parenchyma); 3) scarce contrast-enhancing parenchymal areas in the collecting and intraparenchymal system, and 4) presence of staghorn calculi in the upper pole (29x14mm), interpolar region (23x17mm) and proximal ureteropelvic junction (24x15mm). Based on these findings compatible with emphysematous pyelonephritis and coraliform lithiasis, it was decided to continue with the antibiotic therapy already established.</p>
			<p>
				<fig id="f1">
					<label>Figure 1</label>
					<caption>
						<title>Body temperature curve of the patient during hospitalization.</title>
					</caption>
					<graphic xlink:href="0120-0011-rfmun-71-03-e11-gf1.png"/>
					<attrib>Source: Own elaboration.</attrib>
				</fig>
			</p>
			<p>
				<fig id="f2">
					<label>Figure 2</label>
					<caption>
						<title>Contrast computed tomography urogram.</title>
					</caption>
					<graphic xlink:href="0120-0011-rfmun-71-03-e11-gf2.png"/>
					<attrib>→ Perirenal collection mixed with liquefied necrotic purulent fluid settled in the fundus with air in the upper part giving rise to renal air-fluid levels, a finding suggestive of class 3B emphysematous pyelonephritis in the left kidney according to Huang's classification.</attrib>
					<attrib>→ Bilateral staghorn calculi with characteristics of coralliform lithiasis. </attrib>
					<attrib>Source: Own elaboration.</attrib>
				</fig>
			</p>
			<p>On the 18<sup>th</sup> day of hospitalization and due to the persistence of intermittent fever and septic shock, it was decided to perform a left nephrectomy, procedure that had no complications (surgical and pathological anatomy findings are shown in <xref ref-type="fig" rid="f3">Figures 3</xref> and <xref ref-type="fig" rid="f4">4</xref>). After surgery, an improvement (albeit slow) in the patient's clinical condition was observed, which allowed discontinuing antibiotic therapy 5 days after nephrectomy (i.e., 23 days of antibiotic therapy in total) and the patient was able to continue receiving her hemodialysis sessions without fever and without the need for vasopressor therapy. Finally, 25 days after her hospital admission, the patient was discharged with indication for outpatient follow-up, after which she was counter-referred to her primary care center.</p>
			<p>
				<fig id="f3">
					<label>Figure 3</label>
					<caption>
						<title>Pathological anatomy: macroscopy of removed kidney. A) Necrotic and hemorrhagic kidney, friable consistency (unfixed kidney); B) Yellowish staghorn calculi; C) Kidney (fixed in 10% formalin) opaque brown with light yellowish (yellow asterisk) and dark brownish (blue arrow) areas in the cortico-medullary zone and pyelocaliceal system. </title>
					</caption>
					<graphic xlink:href="0120-0011-rfmun-71-03-e11-gf3.png"/>
					<attrib>Source: Own elaboration.</attrib>
				</fig>
			</p>
			<p>
				<fig id="f4">
					<label>Figure 4</label>
					<caption>
						<title>Pathological anatomy: microscopy (histopathological study) of the removed kidney. A) No viable renal tissue is identified, ischemic necrosis of glomeruli, tubules and blood vessels [hematoxylin and eosin, 80x]; B) Necrotic and sclerosed glomeruli (blue arrows), and interstitium with mixed inflammatory infiltrate [hematoxylin and eosin, 80x]; C) Neutrophils and lymphocytes (yellow asterisk) [hematoxylin and eosin, 800x]; D) Empty ovoid spaces (yellow asterisk) probably filled with gas prior to tissue processing [hematoxylin and eosin, 400x]; E) Arteriola (green arrow) with slight hyaline sclerosis [hematoxylin and eosin, 200x]; F) Enhancement of collagen fibers, blue color (yellow asterisk) [Masson's trichrome, 400x]. </title>
					</caption>
					<graphic xlink:href="0120-0011-rfmun-71-03-e11-gf4.png"/>
					<attrib>Source: Own elaboration.</attrib>
				</fig>
			</p>
		</sec>
		<sec sec-type="discussion">
			<title>Discussion</title>
			<p>Emphysematous pyelonephritis is an acute and severe necrotizing renal infection<xref ref-type="bibr" rid="B8"><sup>8</sup></xref> that poses a urological emergency,<xref ref-type="bibr" rid="B6"><sup>6</sup></xref> so both diagnosis and treatment should be initiated early.<xref ref-type="bibr" rid="B7"><sup>7</sup></xref> In order to diagnose this condition, a high index of clinical suspicion is required, particularly in women<xref ref-type="bibr" rid="B2"><sup>2</sup></xref> and in patients with DM,<xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B3"><sup>3</sup></xref>immunocompromised,<xref ref-type="bibr" rid="B2"><sup>2</sup></xref> and urinary tract obstructions.<xref ref-type="bibr" rid="B4"><sup>4</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B9"><sup>9</sup></xref>Although the outcome in the present case was satisfactory, it should be noted that the diagnosis was late due to initial limitations regarding access to contrast tomography and nephrectomy at the institution, as well as the hemodynamic instability of the patient. Therefore, in centers where CT or MRI scans are available, these tests should be performed in the first hours of care of patients with pyelonephritis and renal dysfunctions in order to define the treatment to be followed.</p>
			<p>Coraliform lithiasis is one of the most severe forms of renal lithiasis. It is usually associated with urinary tract infections by ureolytic bacteria,<xref ref-type="bibr" rid="B10"><sup>10</sup></xref> some of which behave as facultative anaerobic bacteria that may lead to the destruction of the renal parenchyma in situations of low oxygen concentration through the development of gas, abscesses and renal necrosis.<xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B6"><sup>6</sup></xref>
			</p>
			<p><italic>Escherichia coli</italic> is the most frequently detected pathogen in patients with emphysematous pyelonephritis,<xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B9"><sup>9</sup></xref>followed by <italic>Klebsiella pneumoniae,</italic><xref ref-type="bibr" rid="B2"><sup>
 <italic>2</italic>
</sup></xref><sup>
 <italic>,</italic>
</sup><xref ref-type="bibr" rid="B6"><sup>
 <italic>6</italic>
</sup></xref><sup>
 <italic>,</italic>
</sup><xref ref-type="bibr" rid="B9"><sup>
 <italic>9</italic>
</sup></xref><italic>Proteus mirabilis,</italic><xref ref-type="bibr" rid="B6"><sup>
 <italic>6</italic>
</sup></xref> other enterobacteria <italic>(Enterobacter aerogenes</italic> and <italic>Citrobacter freundií),</italic><xref ref-type="bibr" rid="B9"><sup>
 <italic>9</italic>
</sup></xref><italic>Pseudomonas,</italic><xref ref-type="bibr" rid="B2"><sup>
 <italic>2</italic>
</sup></xref> group D <italic>Streptococcus,</italic> and coagulase-negative <italic>Staphylococcus.</italic><xref ref-type="bibr" rid="B6"><sup>
 <italic>6</italic>
</sup></xref> In some cases, polymicrobial infection has also been reported.<xref ref-type="bibr" rid="B11"><sup>11</sup></xref> In the present case, <italic>Streptococcus</italic> sp and <italic>Escherichia coli,</italic> both carbapenemase-producing strains, were isolated in urine cultures, coagulase-negative <italic>Staphylococcus</italic> was isolated in blood cultures and, after nephrectomy, <italic>Proteus mirabilis,</italic> an extended-spectrum ß-lactamase-producing strain, was found in the culture of the resected kidney.</p>
			<p>Although sometimes the symptomatology of pyelonephritis is not very specific, the symptoms and signs it causes include fever, vomiting, lumbar pain, dysuria, dyspnea, crepitus and pneumaturia, the latter 3 being less frequent.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref> In the case reported here, during hospitalization the patient presented abdominal pain and persistent fever, despite receiving broad-spectrum parenteral antibiotic therapy with third-generation cephalosporins, as well as septic shock and impaired consciousness, conditions strongly associated with mortality in cases of emphysematous pyelonephritis.<xref ref-type="bibr" rid="B7"><sup>7</sup></xref>
			</p>
			<p>Patients with emphysematous pyelonephritis usually exhibit leukocytosis, thrombocytopenia and impaired renal function, all of which are poor prognostic factors.<xref ref-type="bibr" rid="B12"><sup>12</sup></xref> In this case, the patient not only had leukocytosis and thrombocytopenia, but also persistent symptomatic hypoglycemia; in addition, her impaired renal function was related to the presence of CKD as a complication resulting from poor adherence to treatment for DM.</p>
			<p>Since the diagnosis of emphysematous pyelonephritis is radiological, the development of new diagnostic imaging techniques has made it easier to make a more accurate diagnosis.<xref ref-type="bibr" rid="B13"><sup>13</sup></xref> Computed axial tomography (CAT) is the test of choice as it allows the identification of intraparenchymal or perinephric air, necrosis and heterogeneous multilocular fluid collections.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B14"><sup>14</sup></xref>Moreover, it not only allows the diagnosis of this condition, but also its classification depending on its extension.<xref ref-type="bibr" rid="B13"><sup>13</sup></xref>
			</p>
			<p>Emphysematous pyelonephritis, according to the proposal of Wan <italic>et al.</italic><xref ref-type="bibr" rid="B15"><sup>
 <italic>15</italic>
</sup></xref> made in 1996, is classified in two groups: type I, which refers to renal necrosis with total absence of fluid content on CT or the presence of a streaky/mottled gas pattern demonstrated on radiograph or CT with lung window display, and type II, which is characterized by the presence of adrenal fluid associated with a bubbling gas pattern or by the presence of gas in the collecting system. However, this classification is no longer in use, and the one currently used is the classification suggested in 2000 by Huang &amp; Tseng,<xref ref-type="bibr" rid="B9"><sup>9</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B16"><sup>16</sup></xref>who, based on tomographic findings and looking for a quick decision making process for the management of patients with this condition, proposed 4 groups: class 1: presence of gas only in the collecting system; class 2: presence of gas in the renal parenchyma without extension to the extrarenal area; class 3, divided into 3A: extension of gas or abscess in the perirenal space and 3B: extension of gas or abscess in the pararenal space; and class 4: bilateral emphysematous pyelonephritis.</p>
			<p>Mortality in emphysematous pyelonephritis increases progressively depending on the class, with class 4 having the worst prognosis. In the present case, the tomographic findings of the patient were compatible with class 3B emphysematous pyelonephritis.</p>
			<p>There is currently no consensus on the best treatment for emphysematous pyelonephritis<xref ref-type="bibr" rid="B2"><sup>2</sup></xref> and, in general, regardless of its class, it is recommended that not only supportive medical treatment and broad-spectrum antibiotic therapy be implemented, but also percutaneous drainage and, in the most severe cases, nephrectomy.<xref ref-type="bibr" rid="B3"><sup>3</sup></xref> Thus, percutaneous drainage combined with broad-spectrum antibiotics has been described as the indicated treatment for patients with class 3A and 3B emphysematous pyelonephritis who have less than 2 risk factors (thrombocytopenia, acute deterioration of renal function, altered state of consciousness, and septic shock),<xref ref-type="bibr" rid="B4"><sup>4</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B11"><sup>11</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B16"><sup>16</sup></xref>whereas nephrectomy is indicated for patients with class 4 or class 3A and 3B emphysematous pyelonephritis with more than 2 risk factors<xref ref-type="bibr" rid="B4"><sup>4</sup></xref>,<xref ref-type="bibr" rid="B17"><sup>17</sup></xref>In the present case, since the patient presented class 3B emphysematous pyelonephritis and had more than 2 risk factors, CKD with the need for hemodialysis and chorionic lithiasis, a nephrectomy was performed.</p>
			<p>Antibiotic therapy should be started early and be directed mainly against gram-negative bacteria, as these are the most frequently isolated etiologic agents.<xref ref-type="bibr" rid="B11"><sup>11</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B17"><sup>17</sup></xref>The duration of treatment varies depending on the surgical management and the clinical status, comorbidities, and clinical progress of the patient. In the present case, the extent of the lesion, the presence of drug-resistant bacteria and the multiple comorbidities would explain her initially unfavorable progress, so it is important to emphasize that the patient's condition improved after nephrectomy despite the presence of carbapenemase-producing bacteria.</p>
			<p>According to the literature, there are some factors that are associated with increased mortality in patients with emphysematous pyelonephritis, namely: having bilateral emphysematous pyelonephritis, having class 1 emphysematous pyelonephritis, having thrombocytopenia, receiving only conservative treatment (fluid resuscitation, administration of antimicrobials, and control of DM without percutaneous drainage),<xref ref-type="bibr" rid="B18"><sup>18</sup></xref> having elevated creatinine levels, and presenting septic shock and altered consciousness.<xref ref-type="bibr" rid="B19"><sup>19</sup></xref> In the present case, despite the patient's multiple comorbidities and the presence of poor prognostic factors (emphysematous pyelonephritis, thrombocytopenia, septic shock, and altered consciousness), a slow but satisfactory clinical progress was achieved by initiating antibiotic therapy and performing a nephrectomy.</p>
		</sec>
		<sec sec-type="conclusions">
			<title>Conclusion</title>
			<p>Emphysematous pyelonephritis is a rare and severe infection that should always be suspected in women with DM with poor adherence to therapy, poor response to antibiotic therapy, and chorionic lithiasis. Since it is a urological emergency, its early diagnosis and timely treatment are essential, being CT the diagnostic test of choice because it not only allows to make the diagnosis, but also to establish the prognosis and the most appropriate treatment.</p>
		</sec>
	</body>
	<back>
		<ack>
			<title>Acknowledgments</title>
			<p>None stated by the authors.</p>
		</ack>
		<ref-list>
			<title>References</title>
			<ref id="B1">
				<label>1</label>
				<mixed-citation>1. Deoraj S, Zakharious F, Nasim A, Missouris C. Emphysematous pyelonephritis: Outcomes of conservative management and literature review. BMJ Case Rep. 2018;2018:bcr2018225931. <ext-link ext-link-type="uri" xlink:href="https://doi.org/k4nt">https://doi.org/k4nt</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Deoraj</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Zakharious</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Nasim</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Missouris</surname>
							<given-names>C</given-names>
						</name>
					</person-group>
					<article-title>Emphysematous pyelonephritis: Outcomes of conservative management and literature review</article-title>
					<source>BMJ Case Rep</source>
					<year>2018</year>
					<issue>2018</issue>
					<fpage>bcr2018225931</fpage>
					<lpage>bcr2018225931</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/k4nt">https://doi.org/k4nt</ext-link>
				</element-citation>
			</ref>
			<ref id="B2">
				<label>2</label>
				<mixed-citation>2. Aboumarzouk OM, Hughes O, Narahari K, Coulthard R, Kynaston H, Chlosta P, <italic>et al</italic>. Emphysematous pyelonephritis: Time for a management plan with an evidence-based approach. Arab J Urol. 2014;12(2):106-15. <ext-link ext-link-type="uri" xlink:href="https://doi.org/gcbmkd">https://doi.org/gcbmkd</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Aboumarzouk</surname>
							<given-names>OM</given-names>
						</name>
						<name>
							<surname>Hughes</surname>
							<given-names>O</given-names>
						</name>
						<name>
							<surname>Narahari</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Coulthard</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Kynaston</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Chlosta</surname>
							<given-names>P</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Emphysematous pyelonephritis: Time for a management plan with an evidence-based approach</article-title>
					<source>Arab J Urol</source>
					<year>2014</year>
					<volume>12</volume>
					<issue>2</issue>
					<fpage>106</fpage>
					<lpage>115</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/gcbmkd">https://doi.org/gcbmkd</ext-link>
				</element-citation>
			</ref>
			<ref id="B3">
				<label>3</label>
				<mixed-citation>3. Song Y, Shen X. Diabetic ketoacidosis complicated by emphysematous pyelonephritis: A case report and literature review. BMC Urol. 2020;20(1):6. <ext-link ext-link-type="uri" xlink:href="https://doi.org/k4pj">https://doi.org/k4pj</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Song</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Shen</surname>
							<given-names>X.</given-names>
						</name>
					</person-group>
					<article-title>Diabetic ketoacidosis complicated by emphysematous pyelonephritis: A case report and literature review</article-title>
					<source>BMC Urol</source>
					<year>2020</year>
					<volume>20</volume>
					<issue>1</issue>
					<fpage>6</fpage>
					<lpage>6</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/k4pj">https://doi.org/k4pj</ext-link>
				</element-citation>
			</ref>
			<ref id="B4">
				<label>4</label>
				<mixed-citation>4. Ciccarese F, Brandi N, Corcioni B, Golfieri R, Gaudiano C. Complicated pyelonephritis associated with chronic renal stone disease. Radiol Med. 2021;126(4):505-16. <ext-link ext-link-type="uri" xlink:href="https://doi.org/k4kd">https://doi.org/k4kd</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Ciccarese</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Brandi</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Corcioni</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>Golfieri</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Gaudiano</surname>
							<given-names>C</given-names>
						</name>
					</person-group>
					<article-title>Complicated pyelonephritis associated with chronic renal stone disease</article-title>
					<source>Radiol Med</source>
					<year>2021</year>
					<volume>126</volume>
					<issue>4</issue>
					<fpage>505</fpage>
					<lpage>516</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/k4kd">https://doi.org/k4kd</ext-link>
				</element-citation>
			</ref>
			<ref id="B5">
				<label>5</label>
				<mixed-citation>5. Moudi E, Darzi M, Ramzani S, Akbarzadeh Pasha A. Xanthogranulomatous pyelonephritis combined with emphysematous pyelonephritis: A rare case report. Caspian J Intern Med. 2021;12(Suppl 2):S505-S508. <ext-link ext-link-type="uri" xlink:href="https://doi.org/k4j6">https://doi.org/k4j6</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Moudi</surname>
							<given-names>E</given-names>
						</name>
						<name>
							<surname>Darzi</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Ramzani</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Akbarzadeh Pasha</surname>
							<given-names>A</given-names>
						</name>
					</person-group>
					<article-title>Xanthogranulomatous pyelonephritis combined with emphysematous pyelonephritis: A rare case report</article-title>
					<source>Caspian J Intern Med</source>
					<year>2021</year>
					<volume>12</volume>
					<supplement>2</supplement>
					<fpage>S505</fpage>
					<lpage>S508</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/k4j6">https://doi.org/k4j6</ext-link>
				</element-citation>
			</ref>
			<ref id="B6">
				<label>6</label>
				<mixed-citation>6. Muñoz-Lumbreras EG, Michel-Ramírez JM, Gaytán-Murguía M, Gil-García JF, Morales-Ordáz O, Lujano-Pedraza H, <italic>et al</italic>. Pielonefritis enfisematosa: Revisión de la fisiopatología y tratamiento. Rev. Mex. Urol. 2019;79(1):1-14. <ext-link ext-link-type="uri" xlink:href="https://doi.org/k4pw">https://doi.org/k4pw</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Muñoz-Lumbreras</surname>
							<given-names>EG</given-names>
						</name>
						<name>
							<surname>Michel-Ramírez</surname>
							<given-names>JM</given-names>
						</name>
						<name>
							<surname>Gaytán-Murguía</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Gil-García</surname>
							<given-names>JF</given-names>
						</name>
						<name>
							<surname>Morales-Ordáz</surname>
							<given-names>O</given-names>
						</name>
						<name>
							<surname>Lujano-Pedraza</surname>
							<given-names>H</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Pielonefritis enfisematosa: Revisión de la fisiopatología y tratamiento</article-title>
					<source>Rev. Mex. Urol</source>
					<year>2019</year>
					<volume>79</volume>
					<issue>1</issue>
					<fpage>1</fpage>
					<lpage>14</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/k4pw">https://doi.org/k4pw</ext-link>
				</element-citation>
			</ref>
			<ref id="B7">
				<label>7</label>
				<mixed-citation>7. Ngo XT, Nguyen TT, Dobbs RW, Thai MS, Vu DH, Dinh LQV, <italic>et al</italic>. Prevalence and Risk Factors of Mortality in Emphysematous Pyelonephritis Patients: A Meta-Analysis. World J Surg. 2022;46(10):2377-88. <ext-link ext-link-type="uri" xlink:href="https://doi.org/k4px">https://doi.org/k4px</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Ngo</surname>
							<given-names>XT</given-names>
						</name>
						<name>
							<surname>Nguyen</surname>
							<given-names>TT</given-names>
						</name>
						<name>
							<surname>Dobbs</surname>
							<given-names>RW</given-names>
						</name>
						<name>
							<surname>Thai</surname>
							<given-names>MS</given-names>
						</name>
						<name>
							<surname>Vu</surname>
							<given-names>DH</given-names>
						</name>
						<name>
							<surname>Dinh</surname>
							<given-names>LQV</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Prevalence and Risk Factors of Mortality in Emphysematous Pyelonephritis Patients: A Meta-Analysis</article-title>
					<source>World J Surg</source>
					<year>2022</year>
					<volume>46</volume>
					<issue>10</issue>
					<fpage>2377</fpage>
					<lpage>2388</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/k4px">https://doi.org/k4px</ext-link>
				</element-citation>
			</ref>
			<ref id="B8">
				<label>8</label>
				<mixed-citation>8. Desai R, Batura D. A systematic review and meta-analysis of risk factors and treatment choices in emphysematous pyelonephritis. Int Urol Nephrol. 2022;54(4):717-36. <ext-link ext-link-type="uri" xlink:href="https://doi.org/k4kc">https://doi.org/k4kc</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Desai</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Batura</surname>
							<given-names>D.</given-names>
						</name>
					</person-group>
					<article-title>A systematic review and meta-analysis of risk factors and treatment choices in emphysematous pyelonephritis</article-title>
					<source>Int Urol Nephrol</source>
					<year>2022</year>
					<volume>54</volume>
					<issue>4</issue>
					<fpage>717</fpage>
					<lpage>736</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/k4kc">https://doi.org/k4kc</ext-link>
				</element-citation>
			</ref>
			<ref id="B9">
				<label>9</label>
				<mixed-citation>9. Batirel A, Regmi SK, Singh P, Mert A, Konety BR, Kumar R. Urological infections in the developing world: An increasing problem in developed countries. World J Urol. 2020;38(11):2681-91. <ext-link ext-link-type="uri" xlink:href="https://doi.org/gg5gpf">https://doi.org/gg5gpf</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Batirel</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Regmi</surname>
							<given-names>SK</given-names>
						</name>
						<name>
							<surname>Singh</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Mert</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Konety</surname>
							<given-names>BR</given-names>
						</name>
						<name>
							<surname>Kumar</surname>
							<given-names>R</given-names>
						</name>
					</person-group>
					<article-title>Urological infections in the developing world: An increasing problem in developed countries</article-title>
					<source>World J Urol</source>
					<year>2020</year>
					<volume>38</volume>
					<issue>11</issue>
					<fpage>2681</fpage>
					<lpage>2691</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/gg5gpf">https://doi.org/gg5gpf</ext-link>
				</element-citation>
			</ref>
			<ref id="B10">
				<label>10</label>
				<mixed-citation>10. Romano J, Estrada C, Suárez N. Litiasis coraliforme. Aten Primaria. 2019;51(7):452-3. <ext-link ext-link-type="uri" xlink:href="https://doi.org/k4p2">https://doi.org/k4p2</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Romano</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Estrada</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Suárez</surname>
							<given-names>N</given-names>
						</name>
					</person-group>
					<article-title>Litiasis coraliforme</article-title>
					<source>Aten Primaria</source>
					<year>2019</year>
					<volume>51</volume>
					<issue>7</issue>
					<fpage>452</fpage>
					<lpage>453</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/k4p2">https://doi.org/k4p2</ext-link>
				</element-citation>
			</ref>
			<ref id="B11">
				<label>11</label>
				<mixed-citation>11. Lu YC, Hong JH, Chiang BJ, Pong YH, Hsueh PR, Huang CY, <italic>et al</italic>. Recommended initial antimicrobial therapy for emphysematous pyelonephritis: 51 Cases and 14-year-experience of a tertiary referral center. Medicine (Baltimore). 2016;95(21):e3573. <ext-link ext-link-type="uri" xlink:href="https://doi.org/k4p4">https://doi.org/k4p4</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Lu</surname>
							<given-names>YC</given-names>
						</name>
						<name>
							<surname>Hong</surname>
							<given-names>JH</given-names>
						</name>
						<name>
							<surname>Chiang</surname>
							<given-names>BJ</given-names>
						</name>
						<name>
							<surname>Pong</surname>
							<given-names>YH</given-names>
						</name>
						<name>
							<surname>Hsueh</surname>
							<given-names>PR</given-names>
						</name>
						<name>
							<surname>Huang</surname>
							<given-names>CY</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Recommended initial antimicrobial therapy for emphysematous pyelonephritis: 51 Cases and 14-year-experience of a tertiary referral center</article-title>
					<source>Medicine</source>
					<publisher-loc>Baltimore</publisher-loc>
					<year>2016</year>
					<volume>95</volume>
					<issue>21</issue>
					<elocation-id>e3573</elocation-id>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/k4p4">https://doi.org/k4p4</ext-link>
				</element-citation>
			</ref>
			<ref id="B12">
				<label>12</label>
				<mixed-citation>12. Olvera-Posada D, Armengod-Fischer G, Vázquez-Lavista L, Maldonado-Ávila M, Rosas-Nava E, Manzanilla-García H, <italic>et al</italic>. Emphysematous pyelonephritis: Multicenter clinical and therapeutic experience in Mexico. Urology. 2014;83(6):1280-4. <ext-link ext-link-type="uri" xlink:href="https://doi.org/f2rzpm">https://doi.org/f2rzpm</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Olvera-Posada</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Armengod-Fischer</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Vázquez-Lavista</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Maldonado-Ávila</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Rosas-Nava</surname>
							<given-names>E</given-names>
						</name>
						<name>
							<surname>Manzanilla-García</surname>
							<given-names>H</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Emphysematous pyelonephritis: Multicenter clinical and therapeutic experience in Mexico</article-title>
					<source>Urology</source>
					<year>2014</year>
					<volume>83</volume>
					<issue>6</issue>
					<fpage>1280</fpage>
					<lpage>1284</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/f2rzpm">https://doi.org/f2rzpm</ext-link>
				</element-citation>
			</ref>
			<ref id="B13">
				<label>13</label>
				<mixed-citation>13. El-Ghar MA, Farg H, Sharaf DE, El-Diasty T. CT and MRI in Urinary Tract Infections: A Spectrum of Different Imaging Findings. Medicina (Kaunas). 2021;57(1):32. <ext-link ext-link-type="uri" xlink:href="https://doi.org/k4ng">https://doi.org/k4ng</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>El-Ghar</surname>
							<given-names>MA</given-names>
						</name>
						<name>
							<surname>Farg</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Sharaf</surname>
							<given-names>DE</given-names>
						</name>
						<name>
							<surname>El-Diasty</surname>
							<given-names>T</given-names>
						</name>
					</person-group>
					<article-title>CT and MRI in Urinary Tract Infections: A Spectrum of Different Imaging Findings</article-title>
					<source>Medicina</source>
					<publisher-loc>Kaunas</publisher-loc>
					<year>2021</year>
					<volume>57</volume>
					<issue>1</issue>
					<fpage>32</fpage>
					<lpage>32</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/k4ng">https://doi.org/k4ng</ext-link>
				</element-citation>
			</ref>
			<ref id="B14">
				<label>14</label>
				<mixed-citation>14. Nepal P, Ojili V, Kaur N, Tirumani SH, Nagar A. Gas where it shouldn't be! Imaging spectrum of emphysematous infections in the abdomen and pelvis. AJR Am J Roentgenol. 2021;216(3):812-23. <ext-link ext-link-type="uri" xlink:href="https://doi.org/gpjdww">https://doi.org/gpjdww</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Nepal</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Ojili</surname>
							<given-names>V</given-names>
						</name>
						<name>
							<surname>Kaur</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Tirumani</surname>
							<given-names>SH</given-names>
						</name>
						<name>
							<surname>Nagar</surname>
							<given-names>A</given-names>
						</name>
					</person-group>
					<article-title>Gas where it shouldn't be! Imaging spectrum of emphysematous infections in the abdomen and pelvis</article-title>
					<source>AJR Am J Roentgenol</source>
					<year>2021</year>
					<volume>216</volume>
					<issue>3</issue>
					<fpage>812</fpage>
					<lpage>823</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/gpjdww">https://doi.org/gpjdww</ext-link>
				</element-citation>
			</ref>
			<ref id="B15">
				<label>15</label>
				<mixed-citation>15. Wan YL, Lo SK, Bullard MJ, Chang PL, Lee TY. Predictors of outcome in emphysematous pyelonephritis. J Urol. 1998;159(2):369-73.<ext-link ext-link-type="uri" xlink:href="https://doi.org/bgfjwm">https://doi.org/bgfjwm</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Wan</surname>
							<given-names>YL</given-names>
						</name>
						<name>
							<surname>Lo</surname>
							<given-names>SK</given-names>
						</name>
						<name>
							<surname>Bullard</surname>
							<given-names>MJ</given-names>
						</name>
						<name>
							<surname>Chang</surname>
							<given-names>PL</given-names>
						</name>
						<name>
							<surname>Lee</surname>
							<given-names>TY</given-names>
						</name>
					</person-group>
					<article-title>Predictors of outcome in emphysematous pyelonephritis</article-title>
					<source>J Urol</source>
					<year>1998</year>
					<volume>159</volume>
					<issue>2</issue>
					<fpage>369</fpage>
					<lpage>373</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/bgfjwm">https://doi.org/bgfjwm</ext-link>
				</element-citation>
			</ref>
			<ref id="B16">
				<label>16</label>
				<mixed-citation>16. Huang JJ, Tseng CC. Emphysematous pyelonephritis: Clinico radiological classification, management, prognosis and pathogenesis. Arch Intern Med. 2000;160(6):797-805. <ext-link ext-link-type="uri" xlink:href="https://doi.org/dm4q2j">https://doi.org/dm4q2j</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Huang</surname>
							<given-names>JJ</given-names>
						</name>
						<name>
							<surname>Tseng</surname>
							<given-names>CC</given-names>
						</name>
					</person-group>
					<article-title>Emphysematous pyelonephritis: Clinico radiological classification, management, prognosis and pathogenesis</article-title>
					<source>Arch Intern Med</source>
					<year>2000</year>
					<issue>160</issue>
					<volume>6</volume>
					<fpage>797</fpage>
					<lpage>805</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/dm4q2j">https://doi.org/dm4q2j</ext-link>
				</element-citation>
			</ref>
			<ref id="B17">
				<label>17</label>
				<mixed-citation>17. Kang CI, Kim J, Park DW, Kim BN, Ha US, Lee SJ, <italic>et al</italic>. Clinical practice guidelines for the antibiotic treatment of community-acquired urinary tract infections. Infect Chemother. 2018;50(1):67-100. <ext-link ext-link-type="uri" xlink:href="https://doi.org/gjh92p">https://doi.org/gjh92p</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Kang</surname>
							<given-names>CI</given-names>
						</name>
						<name>
							<surname>Kim</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Park</surname>
							<given-names>DW</given-names>
						</name>
						<name>
							<surname>Kim</surname>
							<given-names>BN</given-names>
						</name>
						<name>
							<surname>Ha</surname>
							<given-names>US</given-names>
						</name>
						<name>
							<surname>Lee</surname>
							<given-names>SJ</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Clinical practice guidelines for the antibiotic treatment of community-acquired urinary tract infections</article-title>
					<source>Infect Chemother</source>
					<year>2018</year>
					<volume>50</volume>
					<issue>1</issue>
					<fpage>67</fpage>
					<lpage>100</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/gjh92p">https://doi.org/gjh92p</ext-link>
				</element-citation>
			</ref>
			<ref id="B18">
				<label>18</label>
				<mixed-citation>18. Falagas ME, Alexiou VG, Giannopoulou KP, Siempos II. Risk factors formortality in patients with emphysematous pyelonephritis: A meta-analysis. J Urol. 2007;178(3):880-5. <ext-link ext-link-type="uri" xlink:href="https://doi.org/bjfngp">https://doi.org/bjfngp</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Falagas</surname>
							<given-names>ME</given-names>
						</name>
						<name>
							<surname>Alexiou</surname>
							<given-names>VG</given-names>
						</name>
						<name>
							<surname>Giannopoulou</surname>
							<given-names>KP</given-names>
						</name>
						<name>
							<surname>Siempos</surname>
							<given-names>II</given-names>
						</name>
					</person-group>
					<article-title>Risk factors formortality in patients with emphysematous pyelonephritis: A meta-analysis</article-title>
					<source>J Urol</source>
					<year>2007</year>
					<volume>178</volume>
					<issue>3</issue>
					<fpage>880</fpage>
					<lpage>885</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/bjfngp">https://doi.org/bjfngp</ext-link>
				</element-citation>
			</ref>
			<ref id="B19">
				<label>19</label>
				<mixed-citation>19. Nana GR, Brodie A, Akhter W, Karim O, Motiwala H. Nephroureterectomy for emphysematous pyelonephritis: An aggressive approach is sometimes necessary. A case report and literature review. Int J Surg Case Rep. 2015;10:179-82. <ext-link ext-link-type="uri" xlink:href="https://doi.org/k4qd">https://doi.org/k4qd</ext-link>.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Nana</surname>
							<given-names>GR</given-names>
						</name>
						<name>
							<surname>Brodie</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Akhter</surname>
							<given-names>W</given-names>
						</name>
						<name>
							<surname>Karim</surname>
							<given-names>O</given-names>
						</name>
						<name>
							<surname>Motiwala</surname>
							<given-names>H</given-names>
						</name>
					</person-group>
					<article-title>Nephroureterectomy for emphysematous pyelonephritis: An aggressive approach is sometimes necessary. A case report and literature review</article-title>
					<source>Int J Surg Case Rep</source>
					<year>2015</year>
					<issue>10</issue>
					<fpage>179</fpage>
					<lpage>182</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/k4qd">https://doi.org/k4qd</ext-link>
				</element-citation>
			</ref>
		</ref-list>
		<fn-group>
			<fn fn-type="other" id="fn1">
				<label>How to cite:</label>
				<p> Azañero-Haro J, Segura-Gago G, Benavides-Samame A, Chirinos-Molina T, Soto A. Emphysematous pyelonephritis as a complication of staghorn calculi: A case report. Rev. Fac. Med. 2023;71(3):e102546. English. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.15446/revfacmed.v71n3.102546">https://doi.org/10.15446/revfacmed.v71n3.102546</ext-link>.</p>
			</fn>
			<fn fn-type="other" id="fn2">
				<label>Cómo citar:</label>
				<p> Azañero-Haro J, Segura-Gago G, Benavides-Samame A, Chirinos-Molina T, Soto A. [Pielonefritis enfisematosa como complicación de litiasis coraliforme: Reporte de un caso]. Rev. Fac. Med. 2023;71(3):e102456. English. Doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.15446/revfacmed.v71n3.102546">https://doi.org/10.15446/revfacmed.v71n3.102546</ext-link>.</p>
			</fn>
		</fn-group>
		<fn-group>
			<fn fn-type="other" id="fn3">
				<label>Ethical considerations</label>
				<p> The present research was authorized by the ethics committee of the Hospital Nacional Hipólito Unanue in accordance with Letter No. 030-2022-CIEI-HNHU dated March 25, 2022.</p>
			</fn>
			<fn fn-type="financial-disclosure" id="fn5">
				<label>Funding</label>
				<p> None stated by the authors.</p>
			</fn>
		</fn-group>
	</back>
</article>